FLUTAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Flutamide, and when can generic versions of Flutamide launch?
Flutamide is a drug marketed by Actavis Labs Fl Inc, Chartwell Rx, Cipla, Norvium Bioscience, and Waylis Therap. and is included in five NDAs.
The generic ingredient in FLUTAMIDE is flutamide. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flutamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flutamide
A generic version of FLUTAMIDE was approved as flutamide by WAYLIS THERAP on September 18th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUTAMIDE?
- What are the global sales for FLUTAMIDE?
- What is Average Wholesale Price for FLUTAMIDE?
Summary for FLUTAMIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 130 |
| Clinical Trials: | 72 |
| Patent Applications: | 4,333 |
| Drug Prices: | Drug price information for FLUTAMIDE |
| DailyMed Link: | FLUTAMIDE at DailyMed |
Recent Clinical Trials for FLUTAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Colorado, Denver | Phase 4 |
| Kafrelsheikh University | Phase 2 |
| 2-Faculty of Science, Kafrelsheikh University, Egypt. | Phase 3 |
Pharmacology for FLUTAMIDE
| Drug Class | Androgen Receptor Inhibitor |
| Mechanism of Action | Androgen Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for FLUTAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for FLUTAMIDE
US Patents and Regulatory Information for FLUTAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | FLUTAMIDE | flutamide | CAPSULE;ORAL | 075820-001 | Sep 18, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | FLUTAMIDE | flutamide | CAPSULE;ORAL | 076224-001 | May 9, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chartwell Rx | FLUTAMIDE | flutamide | CAPSULE;ORAL | 075818-001 | Sep 18, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cipla | FLUTAMIDE | flutamide | CAPSULE;ORAL | 075780-001 | Sep 19, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Waylis Therap | FLUTAMIDE | flutamide | CAPSULE;ORAL | 075298-001 | Sep 18, 2001 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
